OpenBilldrug price receipt

NADAC week of 2026-10-14

POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID

For 473 mL

Pharmacies pay

$19.32 filed

473 × $0.04085 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$27.22 estimated

$19.32 + $2.90 (15%) + $5.00 fee per fill = $27.22

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “potassium chloride” and “potassium chloride oral”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as solution and its route as oral.

FDA lists 7 labelers (the companies named on the label) for its NDCs, among them PAI Holdings, LLC dba PAI Pharma, Aurobindo Pharma Limited and Genus Lifesciences.

FDA lists it under 2 Established Pharmacologic Classes: Osmotic Laxative and Potassium Salt.

The NADAC file of 2026-10-14 prices it under 9 NDCs (National Drug Codes); the FDA directory lists 7 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $19.32 for 473 mL (473 × $0.04085 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The 7 labelers

LabelerNDCsPharmacies pay per unit
Advagen Pharma Limited1$0.04085 per ML filed
Amneal Pharmaceuticals NY LLC1$0.04085 per ML filed
Aurobindo Pharma Limited1$0.04085 per ML filed
Genus Lifesciences1$0.04085 per ML filed
Granules Pharmaceuticals Inc.1$0.04085 per ML filed
PAI Holdings, LLC dba PAI Pharma1$0.04085 per ML filed
Saptalis Pharmaceuticals, LLC1$0.04085 per ML filed
Not listed as a package in the FDA directory2$0.04085 per ML filed
All 9 NDCs, with labeler and price
  • 00121-0948-16 · PAI Holdings, LLC dba PAI Pharma · $0.04085 per ML · eff. 2026-09-23 filed
  • 00603-1542-58 · not listed as a package in the FDA directory · $0.04085 per ML · eff. 2026-09-23 filed
  • 42571-0357-07 · not listed as a package in the FDA directory · $0.04085 per ML · eff. 2026-09-23 filed
  • 59651-0959-47 · Aurobindo Pharma Limited · $0.04085 per ML · eff. 2026-09-23 filed
  • 64950-0320-47 · Genus Lifesciences · $0.04085 per ML · eff. 2026-09-23 filed
  • 69238-1459-02 · Amneal Pharmaceuticals NY LLC · $0.04085 per ML · eff. 2026-09-23 filed
  • 70010-0072-44 · Granules Pharmaceuticals Inc. · $0.04085 per ML · eff. 2026-09-23 filed
  • 71656-0021-16 · Saptalis Pharmaceuticals, LLC · $0.04085 per ML · eff. 2026-09-23 filed
  • 72888-0041-13 · Advagen Pharma Limited · $0.04085 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

14 other products in the NADAC file share an FDA nonproprietary name with POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID.

ProductPharmacies pay per unitMedicare per unit
KLOR-CON 8 MEQ TABLET
brand · tablet, film coated, extended release
$0.11807 per EA filed
eff. 2026-08-19
We don’t know yet
KLOR-CON 10 MEQ TABLET
brand · tablet, film coated, extended release
$0.12092 per EA filed
eff. 2026-09-23
We don’t know yet
KLOR-CON 20 MEQ PACKET
brand · powder, for solution
$0.47003 per EA filed
eff. 2026-09-23
We don’t know yet
KLOR-CON M10 TABLET
brand · tablet, extended release
$0.13269 per EA filed
eff. 2026-09-23
We don’t know yet
KLOR-CON M15 TABLET
brand · tablet, extended release
$0.49604 per EA filed
eff. 2026-09-23
We don’t know yet
KLOR-CON M20 TABLET
brand · tablet, extended release
$0.14218 per EA filed
eff. 2026-09-23
We don’t know yet
POKONZA 10 MEQ PACKET
brand · powder, for solution
$28.26208 per EA filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID this page
generic · solution
$0.04085 per ML filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID
generic · solution
$0.07285 per ML filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CL 20 MEQ PACKET
generic · powder, for solution / for solution
$0.62416 per EA filed
eff. 2026-09-23
$0.24357 per EA filed
Part D 2024 average
POTASSIUM CL ER 8 MEQ CAPSULE
generic · capsule, extended release
$0.09981 per EA filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CL ER 8 MEQ TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.10279 per EA filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CL ER 10 MEQ CAPSULE
generic · capsule, extended release
$0.13741 per EA filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CL ER 10 MEQ TABLET
generic · tablet, film coated, extended release / tablet, extended release / tablet
$0.0828 to $0.12716 per EA filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CL ER 20 MEQ TABLET
generic · tablet, extended release / tablet / tablet, film coated, extended release
$0.14078 to $0.18593 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 9 NDCs’ NADAC prices is $0.04085 per ML filed.

Of the 38 other products in FDA’s Osmotic Laxative class priced per ML, 10 have a higher middle NADAC price and 28 a lower one. The one in the middle is ANTACID ANTI-GAS LIQUID, at $0.01206 per ML filed (eff. 2026-09-23).

Of the 10 other products in FDA’s Potassium Salt class priced per ML, 3 have a higher middle NADAC price and 7 a lower one. The one in the middle is GAVILYTE-G SOLUTION, at $0.00465 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 473 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 473 mL in one package for the 7 of this product’s 9 NDCs it lists (“473 mL in 1 BOTTLE (0121-0948-16)”), so the card starts at one package: 473 ML. Change it to match your prescription.